You Are What Your Genes Eat: A Physician's Honest Take on Nutrigenomics
Dr. RP, MD — Board-Certified, Emergency Medicine & Critical Care Medicine — Founder, Analog Precision Medicine
My father died of heart disease at 55.
That number follows me around. We had our daughter later in life, which makes the math brutal — if I track the same trajectory he did, she's fatherless around age seven. Old enough to understand something went wrong. Young enough that the actual memories would mostly fade. I've spent a fair amount of time thinking about what I'm willing to do to make sure that doesn't happen.
Turns out, quite a lot.
So when I found myself, somewhere in year fifteen of my medical career, carrying a little extra weight, running a lot less, letting my nutrition habits slide because a three-year-old genuinely is a better use of my time than logging macros at 8pm — I got serious again. But differently this time. Not through willpower, which I've watched fail patients for two decades. Through nutrigenomics. I looked at my specific genetic variants, figured out what they meant for how my body actually processes food, and adjusted accordingly. Back to my college weight now. Running distances I hadn't hit in a decade.
Here's what I know about the field — including the parts that are inconvenient.
What Nutrigenomics Is
Single nucleotide polymorphisms — SNPs, which are single-letter differences scattered throughout your DNA — alter the enzymes that metabolize nutrients, the receptors that respond to dietary signals, the transporters that move vitamins and minerals into cells. Same meal, different people, meaningfully different outcomes. The question nutrigenomics asks is a reasonable one: given that everyone's running different genetic hardware, why would we expect identical dietary inputs to produce identical results?
Genome-wide association studies have now catalogued over a thousand genetic loci tied to nutrient metabolism and dietary response.[1] Some of those associations are solid. Others are early-stage findings that haven't held up in larger trials. The job — and it's actually the hard part — is knowing which is which.
Where It Works
Lactase and Dairy
The LCT gene determines whether your body keeps producing lactase into adulthood. Carry two copies of the non-persistence variant and you can't digest lactose — the bloating, cramping, and GI distress after dairy are enzymatic, not psychosomatic. Dietary implication: stop eating lactose, or use supplemental lactase. Unambiguous. No nuance required. This is the template for what a high-confidence nutrigenomic finding looks like.[2]
APOE and Saturated Fat
APOE genotype governs lipid metabolism in ways that matter cardiovascularly. ε4 carriers run higher baseline cholesterol and respond more aggressively to dietary saturated fat than ε3 or ε2 carriers.[3] The Food4Me trial — a large RCT across seven European countries — found that genotype-based dietary advice produced greater reductions in saturated fat consumption than generic recommendations, particularly among ε4 carriers who understood exactly what their genotype meant for their risk.[4]
For me, this was the one that landed hardest. My father's history made APOE status feel urgent rather than academic. There's a difference between “watch your saturated fat” and understanding the biological mechanism by which your specific genotype amplifies cardiovascular risk. Advice and information are not the same thing.
MTHFR and Folate
The C677T variant reduces the efficiency of an enzyme critical to folate metabolism. Carriers need more dietary folate to maintain adequate methylation, and may benefit from the active methylated form of supplemental folate (5-MTHF) rather than standard folic acid — because converting folic acid to its usable form requires the enzyme that's impaired. Elevated homocysteine from suboptimal methylation independently predicts cardiovascular disease risk.[5] Specific variant, specific dietary intervention.
Where It Doesn't — and a Trial You Should Know About
The DIETFITS study, published in JAMA in 2018, randomized 609 overweight adults to healthy low-fat or low-carbohydrate diets for a year. It was designed specifically to test whether a set of three SNPs could predict who would do better on which diet. The answer: no. No genotype-diet interaction. No predictive signal from insulin secretion either. Both diets lost similar weight, and neither the low-fat nor the low-carb genotype patterns predicted outcomes.[6]
“Consumer genetic testing companies have leaned on this claim heavily. They shouldn't.”
This is not a footnote. It's a well-powered Stanford trial that directly tested one of nutrigenomics' most marketed claims and came back null. The specific assertion — that your genes can tell you whether to go low-fat or low-carb for weight loss — is not supported by the best available evidence. Consumer genetic testing companies have leaned on this claim heavily. They shouldn't.
What nutrigenomics can't do yet: reliably predict macronutrient-based weight loss outcomes, replace actual metabolic biomarker data, or be used in isolation without clinical interpretation.
What It Can Do, and Why It Matters
When embedded in a real clinical picture — actual labs, body composition, metabolic function, history, goals — nutrigenomic data adds a layer of specificity that generic recommendations can't match. It tells you things about how your particular biology handles food that no population-level guideline was designed to capture.
My father didn't have this. He died at 55 on dietary advice that was designed for the average person, whoever that is. I don't know if better information would have changed his outcome — medicine doesn't deal in that kind of certainty. But the questions never got asked, and I think about that.
My daughter is three. If I run my father's trajectory, she grows up without me before she starts third grade. Understanding my own biology — specifically, not generically — is the most direct thing I can do about that. It's not the whole plan. But it's a real part of it.
References
- 1.Lagoumintzis G, Afratis NA, Patrinos GP. Nutrigenomics and personalized nutrition: advancing basic, clinical, and translational research. Frontiers in Nutrition. 2024;11:1435475.
- 2.Enattah NS, et al. Identification of a variant associated with adult-type hypolactasia. Nature Genetics. 2002;30(2):233–237.
- 3.Minihane AM, et al. APOE genotype, cardiovascular risk and responsiveness to dietary fat manipulation. Proceedings of the Nutrition Society. 2007;66(2):183–197.
- 4.Fallaize R, et al. The effect of the apolipoprotein E genotype on response to personalized dietary advice intervention: findings from the Food4Me randomized controlled trial. American Journal of Clinical Nutrition. 2016;104(4):827–836.
- 5.McNulty H, et al. Riboflavin, MTHFR genotype and blood pressure: a personalized approach to prevention and treatment of hypertension. Molecular Aspects of Medicine. 2017;53:2–9.
- 6.Gardner CD, et al. Effect of low-fat vs low-carbohydrate diet on 12-month weight loss in overweight adults and the association with genotype pattern or insulin secretion: the DIETFITS randomized clinical trial. JAMA. 2018;319(7):667–679.
Dr. RP, MD is dual board-certified in Emergency Medicine and Critical Care Medicine and is the founder of Analog Precision Medicine, a precision medicine practice in Southern California. This article is for educational purposes only and does not constitute medical advice or establish a physician-patient relationship.
← Back to Blog